# DuraSeal Sealant Post Market Study

> **NCT00704340** · NA · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 237 (actual)

## Conditions studied

- Elective Cranial Procedures With Dural Incision

## Interventions

- **DEVICE:** DuraSeal Dural Sealant System
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT00704340
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2017-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704340, "DuraSeal Sealant Post Market Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00704340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*